The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지

Effects of Korean Traditional Medicine on Murine Hematopiesis (Regulation of Hematopoietic Cytokine & $CD34^{+}$ cell Expression)

수 종의 한약제제가 조혈작용에 미치는 영향

  • 전재현 (경희대학교 한의과대학 간계내과학교실) ;
  • 김영철 (경희대학교 한의과대학 간계내과학교실) ;
  • 이장훈 (경희대학교 한의과대학 간계내과학교실) ;
  • 우흥정 (경희대학교 한의과대학 간계내과학교실)
  • Published : 2001.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : To evaluate the diverse actions of stimulation on the hematopoietic system, 4 formulas (KH I, KH 2, KH 3, KH 4) were studied. Method and Result : RT-PCR was performed to measure the gene expression of hematopoietic cytokines (TPO, GM-CSF, SCF, IL-3). When bone marrow cells were treated with KH 1, 2, 3, 4, the gene expressions of TPO, SCF, IL-3, and GM-CSF were increased. Flow cytometric analysis was performed to measure the expression of CD34+ cell activity. After 72 hrs culture supplemented with KH 1, 2, 3, 4, the percent of CD34+ cell of KH 2, 3, 4 were increased. To measure the expression of colony forming units - granulocyte erythrocytes, macrophages, megakaryocytes (CFU-GEMM) and burst forming unit-erythroid (BFU-E), semisolid clonogenic assay was performed. After 14 days of culture the number of CFU-GEMM and BFU-E of KH I, 2, 3, 4 were significantly increased compared to those of EPO groups (KH 1 P<0.0l, KH 2 P<0.05, KH 3 P<0.001, KH 4 P<0.0l). To determine the intracelluar TPO expression by KH 3, KH 4 in bone marrow cells, intracelluar staining and flow cytometric analysis were performed. After 24 hrs cultures, the TPO expression of the KH 3 and KH 4 treated groups were increased over those of the controlled groups (control : 50%, KH 3 : 87%, KH 4 : 78%). Conclusion : These results suggest that KH I, KH 2, KH 3, KH 4 have hematopoietic effects through increasing the production of hematopoietic cytokines and stimulating the activity of $CD34^{+}$ cells. This study also shows that KH 3 has a more effective hematopoietic effect than KH 1, 2, 4. These results suggest that the formulas (KH I, 2, 3, 4) can be applied to the patients with inappropriate hematopoietic system, and that KH 3 can be the most effective formula among these 4 in treating bone marrow disease in clinics.

Keywords

References

  1. 精校黃帝內經靈樞 홍원식
  2. 肝系內科學 김병운(외)
  3. Exp. Hematol. v.28 no.8 Mesenchymal stem cells : biology and potential clinical uses Deans, R.J.;Moseley, A.B.
  4. J. Cell. Physiol. v.91 no.3 Conditions controlling the proliferation of hematopoietic stem cells in vitro Dexter, T.M.;Allen, T.D.;Lajtha, L.G.
  5. J. Exp. Med. v.174 no.3 Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interactions with fibronectin Verfaillie, C.M.;McCarthy, J.B.;McGlave, P.B.
  6. Exp. Hematol. v.12 no.7 The essential cells of the hematopoietic microenvironment Allen, T.D.;Dexter, T.M.
  7. Exp. Hemtol. v.18 no.7 Hemopoietic progenitor cell binding to the stromal microenvironment in vitro Gordon, M.Y.;Clarke, D.;Atkinson, J.;Greaves, M.F.
  8. J. Hematother. Stem Cell Res. v.10 no.1 Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment Dormady, S.P.;Bashayan, O.;Dougherty, R.;Zhang, X.M.;Basch, R.S.
  9. Important Adv. Oncol. Colony stimulating factors : clinical status Gabrilove, J.L.
  10. Blood v.81 no.10 Ex vivo expansion of enriched peripheral blood CD34 progenitor cells by stem cell factor, interleukin-1${\beta}$(IL-1${\beta}$), IL-6, IL-3, interferon-${\garmma}$, and erythropoietin Brugger, W.;Mocklin, W.;Heimfeld, S.;Berenson, R.J.;Mertelsmann, R.;Kanz, L.
  11. Am. J. Hematol. v.66 no.3 Oral combination chemotherapy in conjunction with filgrastim(G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma : evaluation of the role of G-CSF : quality-of-life analysis and long-term followup Remick, S.C.;Sedransk, N.;Haase, R.F.;Blanchard, C.G.;Ramnes, C.R.;Nazeer, T.;Mastrianni, D.M.;Dezube, B.J.
  12. 대한조혈모세포이식학회지 v.1 조혈모세포 진환에서 동종골수이실후 유전자 재조합형 인과립구-대식세포계 집락성장인자의 효과 최정현;유진홍;박성규;김동욱;이종욱;한치화;민우성;신완식;김춘추;김동집
  13. 左歸飮加味方이 재생불량성빈혈에 미치는 영향 김선민
  14. 사물탕의 항암제 부작용에 관한 실험적 연구 안희덕
  15. Korean J. Immunol. v.21 no.2 Effects of Korean traditional medicine on Murine Hematopoioesis 김승형;임종순
  16. Blood v.90 no.9 Thrombopoietin is synthesized by bone marrow cells Guerriero, A.;Worford, L.;Holland, H.K.;Guo, G.R.;Sheehan, K.Waller, E.K.
  17. Blood v.86 no.4 Modulation of megagryocytopoiesis by thombopoietin : the c-Mp; ligand Banu, N.;Wang, J.F.;Deng, B.;Groopman, J.E.;Avraham, H.
  18. Blood v.86 no.5 Multi-level effects of fit3 ligand on human hematopoiesis : expansion of putative stem cells and proliferation of granulomonocyte progenitors/monocytic precursors Gabbianeli, M.;Pelosi, E.;Montesoro, E.;Valtieri, M.;Luchettir, L.;Samoggia, P.;Vitelli, L.;Barberi, T.;Testa, U.;Lyman, S.(et al.)
  19. Blood v.88 no.9 Synergistic effects of thrombopoietin and graulocytes cology-stimulating factor on neutrophil recovery in myelosuppressed mice Grossmann, A.;Lenox, J.;Deisher, T.A.;Ren, H.P.;Humes,J.M.;Kausansky, K.;Spruse, K.H.
  20. Exp. Hematol. v.24 no.4 Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice Kaushansky, K.;Lin, N.;Grossmann, A.;Humes, J.;Sprugel, K.H.;Broudy, V.C.
  21. Blood v.77 no.10 Effects of murine mast cell growth factor(c-kit protp-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells Broxmeyer, H.E.;Cooper, S.;Lu, L.;Hangoc, G.;Anderson, D.;Cosman, D.;Lyman, S.D.;Williams, D.E.
  22. Guidebook to cytokines and their receptors Nicola, N.A.
  23. Cell Tissue Kinet v.15 no.5 Kinetic analysis of megakarycyte numbers and ploidy levels developing colonies from mouse bone marrow cells Williams, N.;Jackson, H.;
  24. Proc. Natl. Acd. Sci. USA. v.89 no.12 Molecular cloning and characterization of MPL, the human honolog of the v-mpl oncogene : identification of a member of the hematopoietic growth factor receptor superfamily Vigon, I.;Mornon, J.P.;Cocault, L.;Mitjavila, M.T.;Tambourin, P.;Gisselbrecht, S.;Souyri, M.
  25. Blood v.73 no.3 Interacting cytkines regulate in vitron human megakaryocytopoiesis Bruno, E.;Miller, M.E.;Hoffman, R.
  26. Cell v.63 no.6 A putative truncated cytokine receptor gene transduced by the myelopro-liferative leukemia vitus immortalizes hematopoietic progenitors Souyri, M.;Vigon, I.;Penciolelli, J.F.;Heard, J.M.;Tambourin, P.;Wendling, F.
  27. J. Clin. Invest. v.96 no.3 Thrombopoietin expands erythroid progenitors, increases red cell production and enhances erythroid recovery after myelosuppressive therapy Kaushansky, K.;Broudy, V.C.;Grossmann, A.;Humes, J.;Lin, N.;Ren, H.P.;Bailey, M.C.
  28. Blood v.82 no.12 Hematopoietic regulators : redundancy or subtlety? Metcalf, D.
  29. Annu. Rev. Immunol. v.7 Heterogeneity of mast cells and phenotypic change between subpopulations Kitamura, Y.
  30. Blood v.812 Maintenance of high levels of pluripotent hematopoietic stem cells in vitro : effects of stromal cells and c-kit Wineman, J.P.;Nishikawa, S.;Muller-Sieburg, C.E.
  31. Blood v.90 no.4 Stem cell factor and hematopoiesis Broudy, V.C.
  32. J. Cell. Physiol. v.131 no.3 Recombinant murine granulocyte-macrophage(GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture : comparison with the effects of interleukin-3 Koike, K.;Ogawa, M.;Ilhe, J.N.;Miyake, T.;Shimizu, T.;Miyajima, A.;Yokota, T.;Arai, K.
  33. J. Exp. Med. v.167 no.6 Proliferation and differentiation of highly enriched mouse hematopoietic stem cells and progenitor cells in response to defined growth factors Muller-Sieburg, C.E.;Townsend, K.;Weissmann, I.L.;Rennick, D.
  34. Blood v.85 no.7 Thrombopoietin(c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro Broudy, V.C.;Lin, N.L.;Kaushansky, K.
  35. Blood v.74 Hematologic effects of recombinant human granulocyte-macrophage colony stimulating factor in patients with malignancy Lindemann, A.;Hermann, F.;Oster, W.;Haffner, G.;Meyenburg, W.;Souza, L.M.;Mertelsmann, R.
  36. J. Clin. Oncol. v.7 no.10 Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy Morstyn, G.;Campbell, L.;Lieschke, G.;Layton, J.E.;Maher, D.;O'Conner, M.;Green, M.;Sheridan, W.;Vincent, M.;Alton, K.(et al.)
  37. 대한암학회지 v.27 항암화학요법에 의하여 골수억제가 수반된 진행암 환자에서 Recombinant Human Granulocyte-Macrophage Colony stimulation factor(thGM-CSF, LBD-005)의 제 3상 임상연구 : rhGM-CSF의 백혈구 감소증에 대한 효과 이경희;라선영;노재경;이종인;이혜란;ㅂㄱ준오;조재용;정현철;김주항;한지숙;고윤웅;김병수;임호영;최진혁
  38. J. Exp. Med. v.183 no.6 Differential cytokine effects on primitive(CD34-CD38) human hematopoietic cells : novel responses to Flt3-ligand and thrombopoietin Petzer, A.L.;Zandstra, P.W.;Piret, J.M.;Eaves, C.J.
  39. Exp. Hematol. v.25 no.11 Ex vivo expansion of megakaryocyte progenitors : effect of various growth factro combinations on the CD34' progenitor cells from bone marrow and G-CSF-mobilized peripheral blood Gehling, U.M.;Ryder, J.W.;Hogan, C.J.;Hami, L.;McNiece, I.;Franklin, W.;Williams, S.;Helm, K.;King, J.;Shpall, E.J.
  40. Exp. Hematol. v.21 no.2 Primitive hemopoietic stem cells : direct assay of most productive populations by competitive repopylation with simple binomial, correlation and covariance calculations Harrison, D.E.;Jordan, C.T.;Zhong, R.K.(et al.)